Related Experiment Videos
Infectious vaginitis. Selecting therapy and preventing recurrence
M A Goode1, K Grauer, J G Gums
1Department of Hospital Pharmacy Practice and Administration, Medical University of South Carolina, Charleston.
Postgraduate Medicine
|November 1, 1994
Summary
Managing recurrent vaginal infections like candidiasis, trichomoniasis, and bacterial vaginosis requires addressing contributing factors alongside drug therapy. Both topical and oral treatments are effective, with specific considerations for pregnant women and partner management.
Area of Science:
- Gynecology
- Infectious Diseases
- Pharmacology
Background:
- Recurrent vaginal infections, including vaginal candidiasis, trichomoniasis, and bacterial vaginosis, present significant management challenges.
- Predisposing factors and frequent recurrence complicate treatment efficacy.
Purpose of the Study:
- To outline optimal management strategies for common vaginal infections.
- To emphasize the importance of addressing contributing factors beyond pharmacotherapy.
- To review treatment options and safety profiles, particularly in pregnant women.
Main Methods:
- Review of current therapeutic guidelines and clinical evidence for vaginal candidiasis, trichomoniasis, and bacterial vaginosis.
- Comparison of topical versus oral administration routes for available agents.
- Analysis of management recommendations for sexual partners and impact on recurrence.
Main Results:
- Both topical and oral agents demonstrate comparable safety and efficacy for vaginal candidiasis and bacterial vaginosis.
- Oral therapy is preferred for trichomoniasis, with topical clotrimazole as a pregnancy alternative.
- Partner treatment is recommended for trichomoniasis and optional for bacterial vaginosis.
Conclusions:
- Comprehensive management of vaginal infections necessitates addressing predisposing factors to minimize recurrence.
- Treatment strategies should be tailored based on the specific infection and patient status, including pregnancy.
- Further research is needed to clarify the role of male partner treatment in preventing vaginal candidiasis recurrence.